TCL Archive In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting January 14, 1983
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012